课题基金 / 基金详情

TOPOISOMERASE II POISONING AND ANTICANCER DRUG DESIGN

TOPOISOMERASE II POISONING AND ANTICANCER DRUG DESIGN
拓扑异构酶 II 中毒和抗癌药物设计
批准号:
6497983
负责人:
EMMANUEL A THEODORAKIS
金额:
$19.84万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-02-02 至 2005-01-31

项目摘要

项目成果

EMMANUEL A THEODORAKIS的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Topoisomerases are nuclear enzymes that play an essential role in DNA metabolism and have emerged as the receptors for several clinically important anticancer agents. This proposal describes a research program directed toward the chemistry and biology of two classes of natural products that exhibit excellent antitumor activity by "poisoning" topoisomerase II. With a combination of bioorganic, computational and biological studies we aim to elucidate the mode of action of the above compounds and address issues pertaining to their structure-activity relationship. Research along these lines is expected to aid in the development of powerful and selective anticancer agents and could have important implications for cancer treatment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Chemical design of amyloid targeting fluorescent probes
Synthesis of Bioactive Marine Natural Products
Chemical Biology of Caged Garcinia Xanthones
Synthesis of Bioactive Marine Natural Products
海外基金